[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"influenza-vaccination\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:influenza-vaccination":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,42,73],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100390741","influenza-vaccination-acei-and-arb-in-the-evolution-of-sars-cov2-infection-100390741",false,"NCT04367883","Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection","Evaluation of Influenza Vaccination and Treatment With ACEI and ARB in the Evolution of SARS-CoV2 Infection","Inclusion Criteria:\n\n* Hospital Admissions at the Hospital of Terrassa from March 1, 2020 for any cause.\n\nExclusion Criteria:\n\n* None.\n* For comparison of percentage of Influenza vaccination, ACEI and ARB vs general population, patients from outside the reference area of the Terrassa Health Consortium would be excluded.","ALL",{"count":18,"type":19},3000,"ESTIMATED","OBSERVATIONAL","Some authors have proposed the use of the flu vaccine to reduce the severity of COVID-19 cases, while some have proposed the use of ACE Inhibitors (ACEI) or Angiotensin Receptor blockers (ARB), since this virus shares hemagglutinin as a transmission mechanism and acts on the ACE2 enzyme during infection.\n\nOther authors described how none of the elderly patients receiving antihistamines and azythromycin in two nursing homes in Toledo -Spain- during the first wave died or needed hospital admission, even considering that 100% of residents had a positive serological test after that wave. Other authors have described a positive evolution in patients receiving amantadine for their Parkinson's disease.\n\nThe aim is to evaluate whether the admitted patients who are previously vaccinated or those who were already receiving these treatments showed a better evolution.",[23,24,25,26,27,28],"COVID19","Influenza Vaccination","ACE Inhibitors","ARB","Antihistamine Allergy","Amantadine","RECRUITING","2026-03-23",{"date":32,"type":33},"2026-03-25","ACTUAL",{"date":35,"type":33},"2020-03-01",{"date":37,"type":19},"2028-02-24",{"name":39,"class":40},"Consorci Sanitari de Terrassa","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":46,"acronym":4,"eligibilityCriteria":47,"healthyVolunteers":48,"sex":16,"minAge":49,"maxAge":50,"enrollmentInfo":51,"targetDuration":4,"studyType":53,"phases":54,"briefSummary":56,"conditions":57,"keywords":58,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":41},"100616812","administration-of-the-nasal-influenza-vaccine-to-children-in-daycare-or-at-a-healthcare-facility-100616812","NCT07310472","Administration of the Nasal Influenza Vaccine to Children in Daycare or at a Healthcare Facility","Inclusion Criteria:\n\n* Attending early childhood education (daycare) in the city of Turku\n\nExclusion Criteria:\n\n* No exclusion criteria",true,"2 Years","6 Years",{"count":52,"type":19},6000,"INTERVENTIONAL",[55],"NA","The goal of this intervention study is to learn if giving children influenza vaccinations in early childhood education facilities (i.e., daycare) will increase vaccination coverage compared to giving vaccinations only at healthcare. The main question it aims to answer is:\n\n• Does offering children nasal influenza vaccine in daycare result in higher proportion of children getting influenza vaccine.\n\nResearchers will compare daycare setting and healthcare setting as the location of giving influenza vaccines to children to see if more children will get vaccinated if they have an opportunity to receive nasal influenza vaccine at daycare.\n\nParticipants in the intervention group will:\n\n• Have the opportunity to receive influenza vaccine in the daycare or in the healthcare\n\nParticipants in the comparison group will:\n\n• Have the opportunity to receive influenza vaccine in the healthcare only",[24],[59,60,61,62],"Influenza","Children","Vaccination coverage","Nasal influenza vaccine","2026-01-20",{"date":65,"type":33},"2026-01-22",{"date":67,"type":33},"2025-10-27",{"date":69,"type":19},"2026-03-31",{"name":71,"class":72},"Turku University Hospital","OTHER_GOV",{"id":74,"slug":75,"hasResults":11,"nctId":76,"briefTitle":77,"officialTitle":77,"acronym":4,"eligibilityCriteria":78,"healthyVolunteers":48,"sex":16,"minAge":79,"maxAge":4,"enrollmentInfo":80,"targetDuration":4,"studyType":53,"phases":82,"briefSummary":84,"conditions":85,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":41},"100312386","phase-4-study-of-immune-responses-to-influenza-vaccination-100312386","NCT03346772","Study of Immune Responses to Influenza Vaccination","Inclusion Criteria:\n\n* Community-dwelling adults able to provide consent who need influenza vaccination for standard of care\n\nExclusion Criteria:\n\n* febrile illness at time of vaccination\n* active malignancy\n* use of immunosuppressing medications\n* blood donation in the past 60 days\n* influenza vaccinated during the preceding 6 months\n* allergic reactions to influenza vaccination","18 Years",{"count":81,"type":19},75,[83],"PHASE4","Better understanding of the immune responses to influenza vaccination is needed in order to understand situations of poor vaccine response. Adults will receive influenza vaccination and then have peripheral blood drawn at pre-defined intervals in order to study the lymphocyte responses.",[24],"2025-08-13",{"date":88,"type":33},"2025-08-19",{"date":90,"type":33},"2017-10-20",{"date":92,"type":19},"2026-07-01",{"name":94,"class":40},"University of Pennsylvania"]